Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study.
Fiche publication
Date publication
avril 2022
Journal
BMC infectious diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CAILLOT Denis, Pr HERBRECHT Raoul
Tous les auteurs :
Michallet M, Cheikh JE, Herbrecht R, Yakoub-Agha I, Caillot D, Gangneux JP
Lien Pubmed
Résumé
Invasive fungal diseases (IFD) remain a major complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) and are associated with high mortality rates in patients receiving alloHSCT. Antifungal prophylaxis is increasingly being used in the management of IFDs in patients receiving alloHSCT.
Mots clés
Allogeneic hematopoietic stem cell transplantation, Antifungal stewardship, Invasive fungal diseases, Prophylaxis, Prospective, observational study
Référence
BMC Infect Dis. 2022 Apr 9;22(1):352